Tumor Necrosis Factor Inhibitor-Induced Psoriasis in a Pediatric Crohn’s Disease Patient Successfully Treated with Ustekinumab

Journal of Drugs in Dermatology ◽

10.36849/jdd.2020.2106 ◽

2020 ◽

Vol 19 (3) ◽

pp. 328-331 ◽

Author(s):

Lauren Bonomo ◽

Ellen de Moll ◽

Linden Li ◽

Lauren Geller ◽

Michael Gordon ◽

...

Keyword(s):

Crohn’S Disease ◽

Tumor Necrosis Factor ◽

Crohn's Disease ◽

Tumor Necrosis ◽

Disease Patient ◽

Tumor Necrosis Factor Inhibitor ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

S2405 Disseminated Blastomycosis Following Initiation of Tumor Necrosis Factor Inhibitor Therapy for Crohn’s Disease

The American Journal of Gastroenterology ◽

10.14309/01.ajg.0000783152.12620.aa ◽

2021 ◽

Vol 116 (1) ◽

pp. S1020-S1020

Author(s):

Samuel C. Purkey ◽

Mahmoud Shorman

Keyword(s):

Crohn’S Disease ◽

Tumor Necrosis Factor ◽

Crohn's Disease ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Inhibitor ◽

Inhibitor Therapy ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

Role of tumor necrosis factor inhibitor in granulomatous interstitial nephritis secondary to Crohn’s disease

International Urology and Nephrology ◽

10.1007/s11255-012-0362-2 ◽

2012 ◽

Vol 46 (1) ◽

pp. 229-233 ◽

Author(s):

Manish K. Saha ◽

Hamieh Tarek ◽

Vishal Sagar ◽

Paul Abraham

Keyword(s):

Crohn’S Disease ◽

Tumor Necrosis Factor ◽

Crohn's Disease ◽

Interstitial Nephritis ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Inhibitor ◽

Granulomatous Interstitial Nephritis ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

Regression of Hodgkin Lymphoma After Discontinuation of a Tumor Necrosis Factor Inhibitor for Crohn's Disease: A Case Report and Review of the Literature

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2011.03.018 ◽

2011 ◽

Vol 11 (3) ◽

pp. 289-292 ◽

Author(s):

Ryan D. Cassaday ◽

Jeffrey T. Malik ◽

Julie E. Chang

Keyword(s):

Crohn’S Disease ◽

Case Report ◽

Tumor Necrosis Factor ◽

Crohn's Disease ◽

Hodgkin Lymphoma ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Inhibitor ◽

Review Of The Literature ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

Increased expression of tumor necrosis factor in peripheral blood memory CD4+ T cells of patients with Crohn's disease

Gastroenterology ◽

10.1016/s0016-5085(01)81574-2 ◽

2001 ◽

Vol 120 (5) ◽

pp. A317-A317

Author(s):

J DETENA ◽

L MANZANO ◽

J LEAL ◽

A PRIETO ◽

E ANTONIO ◽

...

Keyword(s):

T Cells ◽

Crohn’S Disease ◽

Tumor Necrosis Factor ◽

Crohn's Disease ◽

Peripheral Blood ◽

Cd4 T Cells ◽

Tumor Necrosis ◽

Memory Cd4 T Cells ◽

Necrosis Factor

Download Full-text

Anti-tumor necrosis factor (TNF) treatment decreases apoptosis of gut epithelial cells: A novel mechanism of anti-TNF therapy in experimental Crohn's disease (CD)

Gastroenterology ◽

10.1016/s0016-5085(01)81559-6 ◽

2001 ◽

Vol 120 (5) ◽

pp. A314-A314

Author(s):

M MARINI ◽

J RIVERANIEVES ◽

K SICHER ◽

B WEBER ◽

G BAMIAS ◽

...

Keyword(s):

Crohn’S Disease ◽

Tumor Necrosis Factor ◽

Crohn's Disease ◽

Epithelial Cells ◽

Tumor Necrosis ◽

Necrosis Factor

Download Full-text

Faculty Opinions recommendation of Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718415285.793526150 ◽

2016 ◽

Author(s):

Eduard Stange ◽

Jan Wehkamp

Keyword(s):

Crohn’S Disease ◽

Tumor Necrosis Factor ◽

Crohn's Disease ◽

Induction Therapy ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Antagonist ◽

Factor Antagonist ◽

Necrosis Factor

Download Full-text

A novel combination treatment with apremilast and tumor necrosis factor inhibitor for a patient with refractory intestinal Behcet’s disease

Scandinavian Journal of Rheumatology ◽

10.1080/03009742.2021.1929458 ◽

2021 ◽

pp. 1-2

Author(s):

S Fukui ◽

S Kawaai ◽

H Tamaki ◽

K Fukuda ◽

M Okada

Keyword(s):

Tumor Necrosis Factor ◽

Combination Treatment ◽

Tumor Necrosis ◽

Behcet’S Disease ◽

Tumor Necrosis Factor Inhibitor ◽

Intestinal Behçet’S Disease ◽

Factor Inhibitor ◽

Intestinal Behcet’S Disease ◽

Necrosis Factor ◽

Intestinal Behçet's Disease

Download Full-text

Secukinumab Efficacy on Psoriatic Arthritis GRAPPA-OMERACT Core Domains in Patients with or Without Prior Tumor Necrosis Factor Inhibitor Use: Pooled Analysis of Four Phase 3 Studies

Rheumatology and Therapy ◽

10.1007/s40744-021-00337-5 ◽

2021 ◽

Author(s):

Ana-Maria Orbai ◽

M. Elaine Husni ◽

Dafna D. Gladman ◽

Ying Ying Leung ◽

Stefan Siebert ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Inhibitor ◽

Pooled Analysis ◽

Phase 3 ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

Positive impact of blocking tumor necrosis factor α on the nutritional status in pediatric Crohn’s disease patients

International Journal of Colorectal Disease ◽

10.1007/s00384-008-0578-x ◽

2008 ◽

Vol 24 (1) ◽

pp. 19-25 ◽

Author(s):

A. Diamanti ◽

M. S. Basso ◽

M. Gambarara ◽

B. Papadatou ◽

F. Bracci ◽

...

Keyword(s):

Crohn’S Disease ◽

Tumor Necrosis Factor ◽

Crohn's Disease ◽

Nutritional Status ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

Positive Impact ◽

Factor Α ◽

Necrosis Factor

Download Full-text

Association between tumor necrosis factor inhibitor (TNFi) therapy and changes in C-reactive protein (CRP), blood pressure, and alanine aminotransferase (ALT) among patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2015.02.004 ◽

2015 ◽

Vol 72 (5) ◽

pp. 917-919 ◽

Author(s):

Jashin J. Wu ◽

Christopher G. Rowan ◽

Judith D. Bebchuk ◽

Mary S. Anthony

Keyword(s):

Rheumatoid Arthritis ◽

Blood Pressure ◽

Psoriatic Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Inhibitor ◽

C Reactive Protein ◽

Reactive Protein ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text